Remifentanil post‐conditioning attenuates cardiac ischemia–reperfusion injury via κ or δ opioid receptor activation
Open Access
- 25 February 2010
- journal article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 54 (4), 510-518
- https://doi.org/10.1111/j.1399-6576.2009.02145.x
Abstract
Background: Ischemic pre‐ or post‐conditioning of the heart has been shown to involve opioid receptors. Remifentanil, an ultra‐short‐acting selective μ opioid receptor agonist in clinical use, pre‐conditions the rat heart against ischemia–reperfusion injury. This study investigates whether remifentanil post‐conditioning is also cardioprotective. Methods: Remifentanil post‐conditioning (5‐min infusion at 1, 5, 10 or 20 μg/kg/min) or ischemic post‐conditioning (three cycles of a 10 s reperfusion interspersed with a 10 s ischemia) was induced in an open‐chest rat heart model of ischemia and reperfusion injury, in the presence or absence of nor‐binaltorphimine, naltrindole or CTOP, specific κ, δ and μ opioid receptor antagonists, respectively. The same sequence of experiments was repeated in the isolated heart model using the maximal protective dose of remifentanil from the dose–response studies. Results: Both ischemic and remifentanil post‐conditioning reduced the myocardial infarct size relative to the control group in both models. This cardioprotective effect for both post‐conditioning regimes was prevented by the prior administration of nor‐binaltorphimine and naltrindole but not CTOP. The sole administration of the antagonists had no effect on the size of myocardial infarction. Conclusions: These results indicate that remifentanil post‐conditioning protects the heart from ischemia–reperfusion injury to a similar extent as of ischemic post‐conditioning. This protection involves κ and δ but not μ opioid receptor activation. This drug has great potential as a clinical post‐conditioning modality as it can be given in large doses without prolonged opioid‐related side effects.Keywords
This publication has 29 references indexed in Scilit:
- Intrathecal Morphine Preconditioning Induces Cardioprotection via Activation of Delta, Kappa, and Mu Opioid Receptors in RatsAnesthesia & Analgesia, 2009
- Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Postconditioning Prevents Reperfusion Injury by Activating δ-Opioid ReceptorsAnesthesiology, 2008
- Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signalingCardiovascular Research, 2007
- Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigsHeart, 2007
- The pH Hypothesis of PostconditioningCirculation, 2007
- Cardiac OpioidsProceedings of the Society for Experimental Biology and Medicine, 2000
- Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarctionBiochemistry and Cell Biology, 1992
- Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenolBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987